conferences-collage
JOSHUA SHARLIN Clinical Trials Conducted Outside the United States: New US-FDA Regulations
Understand how US FDA Reviewers Work and Think

BY JOSHUA SHARLIN

Former US FDA Drug Reviewers, Washington, DC, World Class trainer to over 3,500 attendance during

the last 10 years on mission critical topics to deliver US FDA regulatory compliance.

Master consultant to Global Pharmaceutical, Biotech Biologics and Medical Devices Companies

Joshua Sharlin
SURINDER SINGH

Current Regulatory Environment for Clinical Research in India
Opportunities and Challenges

Drug Controller General, India

Dr. Singh is MBBS, MD and is taking keen interest in the regulatory frame work of India. Vast experience in Quality Control,

Vaccine Development and Drug Regulation in the country

Surinder Singh
STANLEY A. EDLAVITCH

The Impact of FDAAA on Drug Safety
Post Marketing Surveillance and Risk Management

Professor, Epidemiology and Director

Graduate Training, School of Medicine University of Missouri Kansas City, United States

Stanley A. Edlavitch, PhD, MA